Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Apr;99(1-3):19-25.
doi: 10.1016/j.jad.2006.08.023. Epub 2006 Sep 26.

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex

Constance M Moore  1 , Joseph Biederman, Janet Wozniak, Eric Mick, Megan Aleardi, Megan Wardrop, Meghan Dougherty, Terri Harpold, Paul Hammerness, Edin Randall, In Kyoon Lyoo, Perry F Renshaw
Affiliations

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex

Constance M Moore et al. J Affect Disord. 2007 Apr.

Abstract

Background: The purpose of this study was to investigate the anterior cingulate cortex (ACC) glutamate/glutamine (Glx) to creatine ratio (Glx/Cr) in two groups of children with Bipolar Disorder (BPD): those exhibiting manic symptoms requiring treatment and those being stably treated with the atypical antipsychotic risperidone. Atypical antipsychotics have been shown to increase serum glutamate levels and ACC Glx/Cr in subjects with schizophrenia. In this study, we hypothesized that the children with BPD in need of treatment would have lower Glx/Cr compared with the children with BPD being stably treated with risperidone.

Methods: Proton MR spectra were acquired, at 1.5 T, from the ACC of eighteen subjects with a DSM-IV diagnosis of BPD: ten (11.10+/-3.48 years; five female) were manic and not medicated with any antipsychotic and eight (10.88+/-2.99 years; one female) were medicated with the atypical antipsychotic risperidone.

Results: Children with BPD exhibiting manic symptoms requiring treatment had lower Glx/Cr than children with BPD being stably treated with the atypical antipsychotic risperidone. The children treated with risperidone also had significantly lower YMRS and CGI-Mania scores than the children not treated with risperidone. Both YMRS and CGI-Mania scores correlated negatively with ACC Glx/Cr levels.

Limitations: The cross-sectional design, small sample size, the use of Glx rather than glutamate or glutamine and the use of Cr ratios rather than absolute concentrations are limitations of this study.

Conclusions: Children with mania have lower Glx/Cr levels than children with BPD being stably treated with the atypical antipsychotic risperidone. Mania may be associated with reduced glutamate/glutamine levels in the ACC: other imaging studies have shown mania associated with hypometabolism in the ACC. These reductions in glutamate/glutamine may be increased following successful treatment with glutamatergic agents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) A 2 cm x 2 cm x 1.2 cm (superior inferior) voxel in the anterior cingulate cortex of a child with BPD; and (b) a proton spectrum (TE=30 ms; TR = 2s) from that voxel with an LCModel fit. NAA: N-acetyl aspartate. Glx: Glutamate/Glutamine Cho: Choline containing compounds. Ino: Inositol containing compounds.
See this image and copyright information in PMC

References

    1. ALTSHULER L, BOOKHEIMER S, PROENZA MA, TOWNSEND J, SABB F, FIRESTINE A, BARTZOKIS G, MINTZ J, MAZZIOTTA J, COHEN MS. Increased amygdala activation during mania: a functional magnetic resonance imaging study. American Journal of Psychiatry. 2005;162:1211–3. - PubMed
    1. BIEDERMAN J, MICK E, WOZNIAK J, ALEARDI M, SPENCER T, FARAONE SV. An open-label trial of risperidone in children and adolescents with bipolar disorder. Journal of Child & Adolescent Psychopharmacology. 2005;15:311–7. - PubMed
    1. BLUMBERG HP, DONEGAN NH, SANISLOW CA, COLLINS S, LACADIE C, SKUDLARSKI P, GUEORGUIEVA R, FULBRIGHT RK, MCGLASHAN TH, GORE JC, KRYSTAL JH. Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology. 2005;183:308–13. - PubMed
    1. BLUMBERG HP, LEUNG HC, SKUDLARSKI P, LACADIE CM, FREDERICKS CA, HARRIS BC, CHARNEY DS, GORE JC, KRYSTAL JH, PETERSON BS. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Archives of General Psychiatry. 2003;60:601–9. - PubMed
    1. CARREY N, MACMASTER FP, SPARKES SJ, KHAN SC, KUSUMAKAR V. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. J Child Adolesc Psychopharmacol. 2002;12:331–6. - PubMed

Publication types

MeSH terms